The National Institutes of Health (NIH) is offering a funding opportunity through the NIDCR Drug, Biologic, Device, and Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement, designated as UG3/UH3. This initiative aims to support the planning and execution of clinical trials that enhance dental, oral, and craniofacial health, utilizing a two-phased approach: a one-year UG3 planning phase followed by a potential five-year UH3 implementation phase. Eligible applicants include higher education institutions, nonprofits, and local or state governments, with a focus on proposals that test FDA-regulated products and involve significant NIH engagement. Interested parties should note that the application deadline is January 6, 2028, and can find further details and contact information at grantsinfo@nih.gov or through the provided link to the full opportunity announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-057.html.